Cold Chain Considerations for Global Commercial Pharma Distribution

By Peli BioThermal

Global commercial distribution of temperature-sensitive pharmaceuticals can seem daunting for both established and emerging life sciences organisations.

Cold chain packaging and shipping considerations change as an organisation shifts from clinical to commercial operation, and new challenges have impacted shipping in general since the advent of Covid-19.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.